Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Deficiency)

v3.3.1.900
Condensed Consolidated Interim Statements of Changes in Shareholders' Equity (Deficiency) - USD ($)
Total
Preferred Stock [Member]
Common Stock [Member]
Additional Paid-in Capital [Member]
Deficit [Member]
Accumulated Other Comprehensive Income [Member]
Opening Balance at Dec. 31, 2013 $ (710,982) $ 0 $ 36,622 $ 1,736,247 $ (2,506,754) $ 22,903
Opening Balance (in shares) at Dec. 31, 2013   0 36,621,885      
Issuance of common shares for cash (Note 9(i)) 2,616,062 $ 0 $ 10,792 2,605,270 0 0
Issuance of common shares for cash (Note 9(i)) (in shares)   0 10,792,335      
Share issue costs (11,609) $ 0 $ 0 (11,609) 0 0
Shares issues on conversion of loans (Notes 9(ii) and (iii)) 239,746 $ 0 $ 1,012 238,734 0 0
Shares issues on conversion of loans (Notes 9(ii) and (iii)) (in shares)   0 1,012,142      
Beneficial conversion feature (Note 7) 27,677 $ 0 $ 0 27,677 0 0
Shares issued on exercise of stock options (Note 9(iv)) 228,875 $ 0 $ 1,311 227,564 0 0
Shares issued on exercise of stock options (Note 9(iv)) (in shares)   0 1,310,734      
Share compensation expense 70,679 $ 0 $ 0 70,679 0 0
Net loss for the period (1,927,197) 0 0 0 (1,927,197) 0
Foreign currency translation (4,165) 0 0 0 0 (4,165)
Closing Balance at Sep. 30, 2014 529,086 $ 0 $ 49,737 4,894,562 (4,433,951) 18,738
Closing Balance (in shares) at Sep. 30, 2014   0 49,737,096      
Opening Balance at Dec. 31, 2013 (710,982) $ 0 $ 36,622 1,736,247 (2,506,754) 22,903
Opening Balance (in shares) at Dec. 31, 2013   0 36,621,885      
Closing Balance at Dec. 31, 2014 (50,439) $ 0 $ 49,737 4,936,456 (5,053,982) 17,350
Closing Balance (in shares) at Dec. 31, 2014   0 49,737,096      
Opening Balance at Sep. 30, 2014 529,086 $ 0 $ 49,737 4,894,562 (4,433,951) 18,738
Opening Balance (in shares) at Sep. 30, 2014   0 49,737,096      
Share compensation expense 41,894 $ 0 $ 0 41,894 0 0
Net loss for the period (620,031) 0 0 0 (620,031) 0
Foreign currency translation (1,388) 0 0 0 0 (1,388)
Closing Balance at Dec. 31, 2014 (50,439) $ 0 $ 49,737 4,936,456 (5,053,982) 17,350
Closing Balance (in shares) at Dec. 31, 2014   0 49,737,096      
Effect of the Reverse Acquisition (Note 9(vii)) 0 $ 0 $ 6,000 (6,000) 0 0
Effect of the Reverse Acquisition (Note 9(vii)) (in shares)   1 6,000,063      
Shares issued on private placement Notes 9(vi) and (viii-xii) 4,789,404 $ 0 $ 16,408 4,772,996 0 0
Shares issued on private placement Notes 9(vi) and (viii-xii) (in shares)   0 16,408,250      
Share compensation expense (Notes 9(v) and 10) 1,695,919 $ 0 $ 263 1,695,656 0 0
Share compensation expense (Notes 9(v) and 10) (in shares)   0 262,904      
Net loss for the period (6,806,643) $ 0 $ 0 0 (6,806,643) 0
Foreign currency translation 24,799 0 0 0 0 24,799
Closing Balance at Sep. 30, 2015 $ (346,960) $ 0 $ 72,408 $ 11,399,108 $ (11,860,625) $ 42,149
Closing Balance (in shares) at Sep. 30, 2015   1 72,408,313